Annvrridhhi Ventures closes trading window ahead of Q1FY27 results
Annvrridhhi Ventures Limited has closed its trading window for insiders starting July 1, 2026, to comply with SEBI regulations. The window will remain shut until 48 hours after the unaudited Q1FY27 results are declared. The Board Meeting date for result approval is yet to be announced.

*this image is generated using AI for illustrative purposes only.
Annvrridhhi Ventures Limited has closed its trading window for designated insiders effective Wednesday, July 1, 2026. The restriction remains in force until the end of forty-eight hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. This measure is implemented to ensure compliance with The SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's internal Code of Conduct for Prevention of Insider Trading.
The trading prohibition applies to the Directors, Promoters, Promoter Group, Designated Persons, and their immediate relatives. The company stated that the specific date for the Board Meeting to consider and approve the financial results for the quarter ended June 30, 2026, will be communicated in due course.
| Key Details | Information |
|---|---|
| Trading Window Closure Start Date | July 1, 2026 |
| Trading Window Reopens | 48 hours after Q1FY27 results declaration |
| Quarter Ended | June 30, 2026 |
| Regulation | SEBI (Prohibition of Insider Trading) Regulations, 2015 |
The disclosure was signed by Sakina Talibhusein Lokhandwala, Company Secretary and Compliance Officer, on June 19, 2026.
Historical Stock Returns for Annvrridhhi Ventures
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.78% | -0.78% | +1.20% | -1.75% | -6.12% | +828.44% |
What market expectations are analysts setting for Annvrridhhi Ventures' Q1 FY27 financial performance?
How might the extended trading window closure impact liquidity and stock volatility leading up to the results announcement?
Will the company provide any forward guidance or strategic updates alongside the unaudited financial results?

































